We are live on ! Find out more
SCM

Stevens Capital Management Portfolio holdings

AUM $649M
1-Year Est. Return 27.37%
This Fund
S&P 500
This Quarter Est. Return
+2.44%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$2.24B
AUM Growth
-$107M
Cap. Flow
-$138M
Cap. Flow %
-6.17%
Top 10 Hldgs %
13.17%
Holding
955
New
308
Increased
134
Reduced
160
Closed
350

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$31.3M
2
MRK icon
Merck
MRK
+$28.9M
3
MS icon
Morgan Stanley
MS
+$28.2M
4
VZ icon
Verizon
VZ
+$27.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$23.8M

Top Sells

Rank Stock Value
1
CME icon
CME Group
CME
+$22.4M
2
DUK icon
Duke Energy
DUK
+$22M
3
CTSH icon
Cognizant
CTSH
+$19.2M
4
FIS icon
Fidelity National Information Services
FIS
+$19M
5
ETN icon
Eaton
ETN
+$18.4M

Sector Composition

Rank Sector Weight
1 Financials 16.11%
2 Healthcare 14.85%
3 Industrials 13.1%
4 Technology 12.1%
5 Consumer Discretionary 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLL
951
DELISTED
Whiting Petroleum Corporation
WLL
-135
Closed -$264K
QIWI
952
DELISTED
QIWI PLC
QIWI
-12,251
Closed -$176K
CY
953
DELISTED
Cypress Semiconductor
CY
-39,557
Closed -$590K
TSS
954
DELISTED
Total System Services, Inc.
TSS
-68,831
Closed -$6.54M
AAN.A
955
DELISTED
The Aaron's Company Inc Class A
AAN.A
-35,757
Closed -$1.88M

Similar funds

Stevens Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Stevens Capital Management held 955 positions worth $2.24B, down 4.6% from $2.34B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Stevens Capital Management withdrew a net $138M in Q2 2019, closing 350 positions and reducing 160 holdings. Its most notable exit was Cognizant, an estimated $19.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Stevens Capital Management opened a new position in Merck worth $30.2M.

  • Stevens Capital Management's largest Q2 2019 buy was Merck: 377,581 shares worth $30.2M.
  • Stevens Capital Management added most to Eli Lilly in Q2 2019, an estimated $31.3M increase.
  • Stevens Capital Management's biggest Q2 2019 reduction was CME Group, cutting an estimated $22.4M.
  • Stevens Capital Management fully exited Cognizant in Q2 2019, selling an estimated $19.2M.
  • Stevens Capital Management's ten largest holdings make up 13% of its $2.24B portfolio in Q2 2019.
  • Stevens Capital Management opened 308 new positions and closed 350 in Q2 2019.
  • Stevens Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.24B.

Based on Stevens Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.